Current and emerging treatment options for Wiskott-Aldrich syndrome.

Expert Rev Clin Immunol

Department of Clinical Immunology and Bone Marrow Transplantation, Great Ormond Street Hospital National Health Service Trust, London WC1N 1JH, UK.

Published: May 2016

Wiskott-Aldrich syndrome is a life-threatening primary immunodeficiency associated with a bleeding tendency, eczema and a high incidence of autoimmunity and malignancy. Stem cell transplantation offers the opportunity of cure for all these complications, and over the past 35 years there has been a remarkable improvement in survival following this treatment. Here, we review advances in management of clinical complications pre- and post-transplant, as well as discuss the morbidity Wiskott-Aldrich syndrome patients experience following treatment. For patients with a poorly matched stem cell donor, recent gene therapy trials demonstrate encouraging results and the potential of low-toxicity therapy for all patients.

Download full-text PDF

Source
http://dx.doi.org/10.1586/1744666X.2015.1062366DOI Listing

Publication Analysis

Top Keywords

wiskott-aldrich syndrome
12
stem cell
8
current emerging
4
emerging treatment
4
treatment options
4
options wiskott-aldrich
4
syndrome wiskott-aldrich
4
syndrome life-threatening
4
life-threatening primary
4
primary immunodeficiency
4

Similar Publications

Mycolactone is a complex macrolide toxin produced by , the causative agent of Buruli ulcer. The aim of this paper is to review the chemistry, biosynthetic, and synthetic pathways of mycolactone A/B to help develop an understanding of the mode of action of these polyketides as well as their therapeutic potential. The synthetic work has largely been driven by the desire to afford researchers enough (≥100 mg) of the pure toxins for systematic biological studies toward understanding their very high biological activities.

View Article and Find Full Text PDF

Objectives: To explore the mechanism by which Wiskott-Aldrich syndrome protein family verprolin-homologous protein 1 (WAVE1) regulates lipopolysaccharide (LPS)-induced mitochondrial metabolic abnormalities and inflammatory responses in macrophages.

Methods: Macrophage cell lines with overexpressed WAVE1 (mouse BMDM and human THP1 cells) were prepared. The macrophages were treated with LPS (500 ng/mL) to simulate sepsis-induced inflammatory responses.

View Article and Find Full Text PDF

Wiskott-Aldrich syndrome (WAS) is a severe X-linked disorder caused by loss-of-function mutations in the WAS gene, responsible for encoding WASP, a key regulator of actin cytoskeleton in all hematopoietic cells except red blood cells. The mechanism underlying microthrombocytopenia, a distinctive feature of WAS and a major contributor to mortality, remains not fully elucidated. In this study, using different gene editing strategies, we corrected mutations in patient-derived WAS-induced pluripotent stem cell lines, generating isogeneic WAS iPSC lines.

View Article and Find Full Text PDF

Purpose: Wiskott-Aldrich syndrome (WAS) is an X-linked genetic disorder characterized by distinctive features including microthrombocytopenia, eczema and recurrent infections. In the present study we report clinical, immunological and molecular spectrum of 41 WAS patients diagnosed over last five years.

Methods: Clinical and family history was collected from case records.

View Article and Find Full Text PDF
Article Synopsis
  • Cortical condensates are transient structures that form in the actin cortex of oocytes and are rich in actin and N-WASP, forming through a phase separation process influenced by chemical kinetics.
  • The study reveals that N-WASP can undergo surface condensation on lipid bilayers, which is a key factor in the formation of these condensates.
  • The dynamics of condensate formation are regulated by a balance between their creation at the surface and the polymerization of actin, shedding light on the control of complex intracellular structures.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!